XRP
All compounds
Fat lossGH Fragment

AOD-9604

Lipolytic Fragment | Targeted Fat Research

Typical Dose
250–500 mcg
Route
Injectable
Variants
5mg

Overview

What is AOD-9604?

AOD-9604 is a modified C-terminal fragment of human growth hormone (residues 176–191) studied for fat metabolism without the systemic GH-like effects on IGF-1 or glucose.

Mechanism of Action

Binds adipocyte beta-3 receptors, stimulating lipolysis and inhibiting lipogenesis. Does not bind the GH receptor — no impact on growth or insulin sensitivity.

Key Benefits

  • Targeted adipose tissue breakdown
  • No effect on blood glucose
  • Preserves lean muscle mass
  • Convenient daily dosing

Research Indications

Stubborn fat reductionEffective
Metabolic rate supportModerate
Cartilage / joint researchModerate

Research Protocols

Disclaimer

These are commonly discussed research protocols and not medical advice. Consult a healthcare provider before use.

GoalDoseFrequencyRoute
Conservative250 mcg1x dailySubcutaneous (AM, fasted)
Standard starting dose300 mcg1x dailySubcutaneous
Typical maintenance400 mcg1x daily 5/7 daysSubcutaneous
Maximum500 mcg1x dailySubcutaneous

Peptide Interactions

Tesamorelin
Enhanced visceral fat reduction
Synergistic
CJC-1295 / Ipamorelin
Synergistic
Semaglutide / Tirzepatide
Compatible
Insulin
Monitor

Side Effects & Safety

Common Side Effects

  • Mild injection-site irritation
  • Occasional headache
  • Transient fatigue

Safety Guidelines

  • For laboratory research use only — not for human consumption
  • Store reconstituted vials at 2–8°C, use within 30 days
  • Rotate injection sites to avoid local irritation
  • Discontinue and consult a clinician if adverse reactions occur

Quality Indicators

  • ≥95% purity verified by HPLC
  • Third-party tested for sterility
  • Lyophilized in sealed multi-dose vial
  • Bacteriostatic water reconstitution
  • Refrigerated cold-chain shipping

What to Expect

  1. 1
    Week 1–2
    Subtle appetite normalization
  2. 2
    Week 3–4
    Visible reduction in soft tissue fat
  3. 3
    Week 5–8
    Improved body composition
  4. 4
    Week 9–12
    Stabilized lipolytic effect

Need a different compound?

Browse all peptides